(Q43918783)

English

Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial

scientific article published in March 2002

Statements

Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial (English)
Ruggero Ridolfi
Vanna Chiarion-Sileni
Michele Guida
Antonella Romanini
Andrea Freschi
Rolando Nortilli
Sonia Brugnara
Patrizia Vitali
Italian Melanoma Intergroup
1 March 2002
1600-1607

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit